Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naïve adults with advanced HIV infection

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)198-199
Number of pages2
JournalInfectious Diseases in Clinical Practice
Volume12
Issue number3
DOIs
StatePublished - Jan 1 2004

Fingerprint

Indinavir
Protease Inhibitors
HIV Infections
Safety
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{214b94690d86429fb7631f194d5949d2,
title = "Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-na{\"i}ve adults with advanced HIV infection",
author = "John Bartlett",
year = "2004",
month = "1",
day = "1",
doi = "10.1097/01.idc.0000129852.72626.0b",
language = "English (US)",
volume = "12",
pages = "198--199",
journal = "Infectious Diseases in Clinical Practice",
issn = "1056-9103",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naïve adults with advanced HIV infection

AU - Bartlett, John

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=85026155325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026155325&partnerID=8YFLogxK

U2 - 10.1097/01.idc.0000129852.72626.0b

DO - 10.1097/01.idc.0000129852.72626.0b

M3 - Article

AN - SCOPUS:85026155325

VL - 12

SP - 198

EP - 199

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

SN - 1056-9103

IS - 3

ER -